Hyper II DHA/EPA, 100 Count Softgels. Product labeling reads in part:"Hyper II DHA/EPA Refined Deep Sea Fish Oil 50% DHA - 30% EPA***Dietary Supplement 100 Softgels***6 65176 05274 3***Manufactured for:HealthMax Products Co. Altadena, CA 91001***".

Healthmaxx Global INC. recalled Hyper II DHA/EPA, 100 Count Softgels. in a Class II action, the FDA tier for products that may cause temporary or medically reversible health effects on Jun 10, 2013.

The recall cites a labeling or packaging error: "In response to a FDA inspection, the firm initiated this voluntary recall of various dietary supplements due to the following problems of mislabeling: 1) product named on the label is not actual product contained; 2)ingredients listed are not actual ingredients contained." Labeling defects matter most when the wrong label conceals an ingredient a consumer is trying to avoid.

The product reached multiple states, recorded by the FDA as "CA, MD, and NY." A multi-state footprint means the same lot can surface in households far from the producer. The recalling firm is based in Hacienda Heights, CA. The recall covers 2863 bottles of product. The FDA has Terminated this recall (first reported Oct 2, 2013), its final lifecycle state, indicating the agency considers the corrective action resolved. The historical record remains useful for tracking a brand's recall pattern over time.